TrialBreast cancer research and treatment2017

IPET study: an FLT-PET window study to assess the activity of the steroid sulfatase inhibitor irosustat in early breast cancer.

Carlo Palmieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.